Skip to main content

Author: Customer Service

BioSyent Declares Second Quarter 2026 Dividend

MISSISSAUGA, Ontario, May 14, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.055 per common share, payable in Canadian Dollars on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. This second quarter 2026 dividend compares to a first quarter dividend of $0.055 per common share. This dividend qualifies as an ‘eligible dividend’ for Canadian income tax purposes. The declaration, timing, amount and payment of future dividends remain at the discretion of the Board of Directors. About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty healthcare products company focused on acquiring or...

Continue reading

Streamex Corp. Reports Q1 2026 Financial Results and Announces Business & Quarterly Update Call

WINTER PARK, Fla., May 14, 2026 (GLOBE NEWSWIRE) —  Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company focused on the tokenization of commodity real-world assets, today announced that it has filed its Q1 2026 financial results and will host an earnings and corporate update presentation on Wednesday, May 20, 2026, at 4:30 p.m. ET. Henry McPhie, Co-Founder & Chief Executive Officer of Streamex, said: “Q1 2026 was a transformative quarter for Streamex. We raised over $40 million in equity capital, fully deleveraged our balance sheet, and launched GLDY. We made our first yield distribution to GLDY holders, paying investors in gold to hold gold for the first time in a product of this kind. We now have a live product, a proven infrastructure platform, a healthy balance sheet, and a growing pipeline....

Continue reading

CORRECTION — Xcel Brands, Inc. Announces First Quarter 2026 Financial Results

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) — In a release issued earlier today by Xcel Brands, Inc (NASDAQ: XELB) please note that the “Conference Call and Webcast” section contained outdated information. The corrected release followsNet loss on a GAAP basis was $2.5 million for the current quarter compared with $2.8 million net loss for the prior year quarter.  Year-to-Date Adjusted EBITDA for 2026 was approximately negative $0.7 million for both the current and prior year quarters.:Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a media and consumer products company with significant expertise in building influencer lead brands, live-steam shopping and social commerce, today announced its financial results for the quarter ended March 31, 2026. Robert W. D’Loren, Chairman and Chief Executive Officer...

Continue reading

Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring (CBGM) technology Company targeting U.S. clinical trial launch in second half of 2026 Peer-Reviewed Studies published in The Journal of Diabetes Research and in the Institute of Electrical and Electronics Engineers (IEEE) Sensors Journal support advancement of Company’s implantable CBGM technology Rutherford, NJ, May 14, 2026 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today reported financial results and recent corporate highlights for the first quarter ended...

Continue reading

Westport Reports First Quarter 2026 Financial Results

~Strong demand for the LNG HPDI trucks drives significant Q1 revenue growth for Cespira; Showcasing the high-pressure CNG storage solution at ACT Expo a defining step towards the North American market ~ VANCOUVER, British Columbia, May 14, 2026 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport“) (TSX:WPRT / Nasdaq:WPRT) today reported financial results for the first quarter ended March 31, 2026, and provided an update on operations. All figures are in U.S. dollars unless otherwise stated. “We are seeing continued momentum in our Cespira joint venture with Volvo Group reflected in a 33% increase in revenue compared to the same quarter in 2025. This performance, includes incremental volumes delivered to a second OEM for a truck trial, is becoming increasingly material to our overall results and reinforces the growing...

Continue reading

Interfor Reports Q1’26 Results

Adjusted EBITDA of $31 million and Net Loss of $63 million  BURNABY, British Columbia, May 14, 2026 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) recorded a net loss in Q1’26 of $63.3 million, or $0.96 per share, compared to a net loss of $104.6 million, or $1.59 per share in Q4’25 and a net loss of $35.1 million, or $0.68 per share in Q1’25. Adjusted EBITDA was $30.7 million on sales of $643.2 million in Q1’26 versus an Adjusted EBITDA loss of $29.2 million on sales of $600.6 million in Q4’25 and Adjusted EBITDA of $48.6 million on sales of $735.5 million in Q1’25.Operational HighlightsLumber prices increased during Q1’26 as reflected in Interfor’s average selling price of $666 per mfbm, up $67 per mfbm versus Q4’25. Lumber prices strengthened across all operating regions primarily from the...

Continue reading

Stardust Power Announces Q1 2026 Financial Results

GREENWICH, Conn., May 14, 2026 (GLOBE NEWSWIRE) — Stardust Power Inc. (Nasdaq: SDST) (“Stardust Power” or the “Company”), an American developer of battery-grade lithium carbonate, today announced its results for the quarter ended March 31, 2026 and provided an update on the continued development of its lithium refinery project in Muskogee, Oklahoma. First Quarter 2026 Business Updates and Subsequent events  Secured the key air quality construction permit for the Muskogee refinery, enabling construction and commissioning. Entered into an institutional investor Letter of Intent for up to $150 million in project-level financing for the Muskogee refinery. Entered into a Letter of Intent to secure up to 15,000 metric tons per annum of lithium chloride feedstock from a California-based brine project. Expanded further the domestic feedstock...

Continue reading

Precipio Announces Q1 2026 Financial Results

Stable revenue performance driven by timing dynamics; expanding product pipeline expected to drive second-half growth NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the first quarter ended March 31, 2026. Below are some of the key financial performance metrics for the Company. Please see the Company’s Form 10-Q which was filed today for additional details.Revenue – $6.71M (vs. $6.69M in Q4-2025; $4.93M in Q1-2025). This was comprised of $6.05M in pathology revenue (up from $5.9M in Q4) and $0.66M in product revenue (down from $0.74M in Q4). The product revenue decline is temporary, and was largely driven by delayed shipment to one of the Company’s largest product customers, shifting revenue recognized to Q2. Adjusted EBITDA...

Continue reading

LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update

BOCA RATON, Fla., May 14, 2026 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (“SEC”) for the first quarter ended March 31, 2026. The report is available on the Company’s website, www.lixte.com, and on the SEC’s website, www.sec.gov. “We are making progress in advancing our lead compound, LB-100, which has consistently shown synergy with today’s chemotherapy and immunotherapy approaches for the treatment of cancer,” said Geordan Pursglove, LIXTE’s Chairman and Chief Executive Officer. “Following a recent study confirming the favorable safety profile of LB-100 in combination with...

Continue reading

Volatus Aerospace Reports First Quarter 2026 Financial Results, Records Highest Q1 Gross Margins in Company’s History

Record Q1 gross margin of 35%, highest Q1 in the Company’s history Revenue of $5.6M, reflecting typical seasonal patterns and broadly consistent with Q1 2025 Working capital of $36.4M, reflecting a strong and stable balance sheet position Graduation to the Toronto Stock Exchange (TSX: FLT) completed March 20, 2026 Launch of SKYDRA™, Company’s first proprietary C-UAS SaaS platform Full acquisition of Synergy Aviation minority interest completed; preferred shares fully redeemed Defence pipeline expanded: NATO RPAS operator training contract; $9M ISR training system initial tranche delivery transitioned to Q2 2026 Subsequent to quarter-end: multi-year specialist training contract with NATO-allied government ministry awardedMONTREAL, May 14, 2026 (GLOBE NEWSWIRE) — Volatus Aerospace Inc. (TSX: FLT) (OTCQX: TAKOF) (FSE:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.